Toshitha Kannan

737 total citations · 1 hit paper
13 papers, 336 citations indexed

About

Toshitha Kannan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Toshitha Kannan has authored 13 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Toshitha Kannan's work include Immune Cell Function and Interaction (4 papers), Immune cells in cancer (3 papers) and HIV Research and Treatment (2 papers). Toshitha Kannan is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immune cells in cancer (3 papers) and HIV Research and Treatment (2 papers). Toshitha Kannan collaborates with scholars based in United States, Japan and Germany. Toshitha Kannan's co-authors include Andrew V. Kossenkov, Rahul Shinde, Gauri Mirji, Mohamed Abdel‐Mohsen, Sajad A. Bhat, Ben Z. Stanger, Qin Liu, Noam Auslander, Aaron R. Goldman and Hsin‐Yao Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Toshitha Kannan

10 papers receiving 332 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer

2022 205 citations Gauri Mirji, Sajad A. Bhat et al. Science Immunology profile →

Peers

Toshitha Kannan

MB

ONCOL

IMMUN

CR

ID

Gauri Mirji United States

Kiichiro Baba Japan

Alina Janney United Kingdom

Tomoki Saito Japan

Keitaro Doi Japan

Zhao Gan China

Hanna Leister Germany

Mai Fujiwara United States

Ian M. Cartwright United States

Zoe X. Malchiodi United States

Gauri Mirji United States

Toshitha Kannan

198 ×0.9

MB

122 ×0.9

ONCOL

78 ×1.0

IMMUN

40 ×1.0

CR

37 ×1.0

ID

Citations per year, relative to Toshitha Kannan Toshitha Kannan (= 1×) peers Gauri Mirji

Countries citing papers authored by Toshitha Kannan

Since Specialization

Citations

This map shows the geographic impact of Toshitha Kannan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshitha Kannan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshitha Kannan more than expected).

Fields of papers citing papers by Toshitha Kannan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshitha Kannan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshitha Kannan. The network helps show where Toshitha Kannan may publish in the future.

Co-authorship network of co-authors of Toshitha Kannan

This figure shows the co-authorship network connecting the top 25 collaborators of Toshitha Kannan. A scholar is included among the top collaborators of Toshitha Kannan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshitha Kannan. Toshitha Kannan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Miyamoto, Taito, Gauri Mirji, Alessio Ugolini, et al.. (2024). Myeloid activation clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer. The Journal of Experimental Medicine. 221(12). 5 indexed citations

2.

Kannan, Toshitha, et al.. (2024). Immune evasion: An imperative and consequence of MYC deregulation. Molecular Oncology. 18(10). 2338–2355. 7 indexed citations

3.

Nie, Hao, Taito Miyamoto, Rafał Zieliński, et al.. (2024). Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade. Nature Communications. 15(1). 2853–2853. 17 indexed citations

4.

Mukha, Dzmitry, Toshitha Kannan, Joel Cassel, et al.. (2024). ACSS1-dependent acetate utilization rewires mitochondrial metabolism to support AML and melanoma tumor growth and metastasis. Cell Reports. 43(12). 114988–114988. 5 indexed citations

5.

Yadav, Anjana, Andrew V. Kossenkov, Toshitha Kannan, et al.. (2024). Association of smoking with neurocognition, inflammatory and myeloid cell activation profiles in people with HIV on antiretroviral therapy. AIDS. 38(15). 2010–2020.

6.

Miyamoto, Taito, Toshitha Kannan, Daniel T. Claiborne, et al.. (2023). 1101 Activation of myeloid cells suppresses metastatic ovarian cancer via tumoricidal neutrophils and IL-27-secreting macrophages. SHILAP Revista de lepidopterología. A1212–A1212.

7.

Tursi, Nicholas J., Ziyang Xu, Susanne N. Walker, et al.. (2023). Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo. Frontiers in Immunology. 14. 1072810–1072810. 3 indexed citations

8.

Miller, Katelyn D., Seamus O’Connor, Toshitha Kannan, et al.. (2023). Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nature Cancer. 4(10). 1491–1507. 78 indexed citations

9.

Tietjen, Ian, Toshitha Kannan, Andrew V. Kossenkov, et al.. (2023). The Natural Stilbenoid (–)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9. Antimicrobial Agents and Chemotherapy. 67(4). e0160022–e0160022. 4 indexed citations

10.

Leu, Julia I-Ju, Toshitha Kannan, Harsh Dweep, et al.. (2023). Common activities and predictive gene signature identified for genetic hypomorphs of TP53. Proceedings of the National Academy of Sciences. 120(7). e2212940120–e2212940120. 5 indexed citations

11.

Mirji, Gauri, Sajad A. Bhat, Mohamed El Sayed, et al.. (2022). The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Science Immunology. 7(75). eabn0704–eabn0704. 205 indexed citations breakdown →

12.

Mirji, Gauri, Mohamed El Sayed, Toshitha Kannan, et al.. (2022). Abstract C023: A microbiome-produced metabolite drives immunostimulatory macrophages and boosts response to immune checkpoint inhibitors in pancreatic cancer. Cancer Research. 82(22_Supplement). C023–C023.

13.

Giron, Leila B., Toshitha Kannan, Natalie N. Kinloch, et al.. (2020). The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal. Journal of Biological Chemistry. 295(41). 14084–14099. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact